Study of the influences of Yokukansan for sleep disturbance in dementia

Trial Profile

Study of the influences of Yokukansan for sleep disturbance in dementia

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2014

At a glance

  • Drugs TJ 54 (Primary)
  • Indications Dementia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Jan 2013 Planned end date added (1 Aug 2013) as reported by University Hospital Medical Information Network - Japan.
    • 26 Oct 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 05 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top